Hepatitis C virus NS5A protein interacts with and negatively regulates the non-receptor protein tyrosine kinase Syk

Journal of General Virology

Volumn 89, Issue 5, 2008, Pages 1231-1242

  Inubushi, Sachiko ^a   Nagano Fujii, Motoko ^a   Kitayama, Kikumi ^a   Tanaka, Motofumi ^a   An, Chunying ^a   Yokozaki, Hiroshi ^a   Yamamura, Hirohei ^b   Nuriya, Hideko ^c   Kohara, Michinori ^c   Sada, Kiyonao ^a,d   Hotta, Hak ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Hyogo Prefectural Institute of Public Health and Environmental Sciences   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^d UNIVERSITY OF FUKUI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTRUCTURAL PROTEIN 5A; PHOSPHOLIPASE C GAMMA1; PROTEIN KINASE SYK; VIRUS RNA; NS 5 PROTEIN, HEPATITIS C VIRUS; NS-5 PROTEIN, HEPATITIS C VIRUS; PHOSPHOLIPASE C GAMMA; PROTEIN TYROSINE KINASE; SIGNAL PEPTIDE; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM; DELETION MUTANT; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HEPATITIS C; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REPLICON; VIRUS CARCINOGENESIS; CELL LINE; CHEMISTRY; DRUG ANTAGONISM; GENE DELETION; HEPATITIS C VIRUS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN ANALYSIS; VIROLOGY;

HEPATITIS C VIRUS;

CELL LINE; CELL MEMBRANE; CYTOPLASM; DOWN-REGULATION; HEPACIVIRUS; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PHOSPHOLIPASE C GAMMA; PHOSPHORYLATION; PROTEIN INTERACTION MAPPING; PROTEIN-TYROSINE KINASES; SEQUENCE DELETION; VIRAL NONSTRUCTURAL PROTEINS;

EID: 44649194072     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.83510-0     Document Type: Article

References (65)

1. Blight K. J., McKeating, J. A. & Rice, C. M. (2002). Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 76, 13001-13014.
2. Cheng, A. M., Rowley, B., Pao, W., Hayday, A., Bolen, J. B. & Pawson, T. (1995). Syk tyrosine kinase required for mouse viability and B-cell development. Nature 378, 303-306.
3. Choo, O. L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W. & Houghton, M. (1989). Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244, 359-362.
4. Chung, K. M., Lee, J., Kim, J. E., Song, O. K., Cho, S., Lim, J., Seedorf, M., Hahm, B. & Jang, S. K. (2000). Nonstructural protein 5A of hepatitis C virus inhibits the function of karyopherin β3. J Virol 74, 5233-5241.
5. Coopman, P. J., Do, M. T., Barth, M., Bowden, E. T., Hayes, A. J., Basyuk, E., Blancato, J. K., Vezza, P. R., McLeskey, S. W. & other authors (2000). The Syk tyrosine kinase suppresses malignant growth of human brmt cancer cells. Nature 406, 742-747.
6. Corey, S. J., Burkhardt, A. L., Bolen, J. B., Geahlen, R. L., Tkatch, L. S. & Tweardy, D. J. (1994). Granulocyte colony-stimulating factor receptor signaling involves the formation of a three-component complex with Lyn and Syk protein-tyrosine kinases. Proc Natl Acad Sci U S A 91, 4683-4687.
7. Costello, P. S., Turner, M., Walters, A. E., Cunningham, C. N., Bauer, P. H., Downward, J. & Tybulewicz, V. L. (1996). Critical role for the tyrosine kinase Syk in signalling through the high affinity IgE receptor of mast cells. Oncogene 13, 2595-2605.
8. Deng, L., Nagano-Fujii, M., Tanaka, M., Nomura-Takigawa, Y., Ikeda, M., Kato, N., Sada, K. & Hotta, H. (2006). NS3 protein of hepatitis C virus associates with the tumor suppressor p53 and inhibits its function in an, NS3 sequence-dependent manner. J Gen Virol 87, 1703-1713.
9. Doi, H., Apichartpiyakul, C., Ohba, K. I., Mizokami, M. & Hotta, H. (1996). Hepatitis C virus (HCV) subtype prevalence in Chiang Mai, Thailand, and identification of novel subtypes of HCV major type 6. J Clin Microbiol 34, 569-574.
10. Evans, M. J., Rice, C. M. & Goff, S. P. (2004). Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA repfication. Proc Natl Acad Sci U S A 101, 13038-13043.
11. Gale, M., Jr, Blakely, C. M., Kwieciszewski, B., Tan, S. L., Dossett, M., Tang, N. M., Korth, M. J., Polyak, S. J., Gretch, D. R. & Katze, M. G. (1998). Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol Cell Biol 18, 5208-5218.
12. 3. EMBO J 16, 6414-6425.
13. Gao, L., Aizaki, H., He, J. W. & Lai, M. M. (2004). Interactions between viral nonstructural proteins and host protein hVAP-33 mediate the formation of Npatitis C virus RNA replication complex on lipid raft. J Virol 78, 3480-3488.
14. Ghosh, A. K., Majumder, M., Steele, R., Yaciuk, P., Chrivia, J., Ray, R. & Ray, R. B. (2000). Hepatitis C virus NS5A protein modulates transcription through a novel cellular transcription factor SRCAP. J Biol Chem 275, 7184-7188.
15. Goodman, P. A., Wood, C. M., Vassilev, A., Mao, C. & Uckun, F. M. (2001). Spleen tyrosine kinase (Syk) deficiency in childhood pro-B cell acute lymphoblastic leukemia. Oncogene 20, 3969-3978.
16. Hamamoto, I., Nishimura, Y., Okamoto, T., Aizaki, H., Liu, M, Mori, M., Abe, T., Suzuki; T., Lai, M. M. C. & other authors (2005). Human VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5B. J Virol 79, 13473-13482.
17. He, Y., Nakao, H., Tan, S. L., Polyak, S. J., Neddermann, P., Vijaysri, S., Jacobs, B. L. & Katze, M. G. (2002). Subversion of cell signaling pathways by hepatitis C virus nonstructural 5A protein via interaction with Grb2 and P85 phosphatidylinositol 3-kinase. J Virol 76, 9207-9217.
18. Hidajat, R., Nagano-Fujii, M., Deng, L., Tanaka, M., Takigawa, Y., Kitazawa, S. & Hotta, H. (2005). Hepatitis C virus NS3 protein interacts with ELKS-δ and ELKS-α, members of a novel protein family involved in intracellular transport and secretory pathways. J Gen Virol 86, 2197-2208.
19. Kaneko, T., Tanji, Y., Satoh, S., Hijikata, M., Asabe, S., Kimura, K. & Shimotohno, K. (1994). Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome. Biochem Biophys Res Commun 205, 320-326.
20. Kurosaki, T., Johnson, S. A., Pao, L., Sada, K., Yamamura, H. & Cambler, J. C. (1995). Role of the Syk au tophosphoryla Lion site and SH2 domains in B cell antigen receptor signaling. J Exp Med 182, 1815-1823.
21. Law, C. L., Chandran, K. A., Sidorenko, S. P. & Clark E. A. (1996). Phospholipase C-γ1 interacts with conserved phosphotyrosyl residues in the linker region of Syk and is a substrate for Syk. Mol Cell Biol 16, 1305-1315.
22. Li, J. & Sidell, N. (2005). Growth-related oncogene produced in human breast cancer cells and regulated by Syk protien-tyrosine kinase. Int J Cancer 117, 14-20.
23. Lindenbach, B. D., Evans, M. J., Syder, A. J., Wolk, B., Tellinghuisen, T. L., Liu, C. C., Maruyama, T., Hynes, R. O., Burton, D. R. & other authors (2005). Complete replication of hepatitis C virus in cell culture. Science 309, 623-626.
24. Lohmann, V., Korner, F., Dobierzewska, A. & Bartenschlager, R. (2001). Mutations in hepatitis C virus RNAs conferring cell culture adaptation. J Virol 75, 1437-1449.
25. Macdonald, A. & Harris, M. (2004). Hepatitis C virus NS5A: tales of a promiscuous protein. J Gen Virol 85, 2485-2502.
26. Macdonald, A., Crowder, K., Street A., McCormick C. & Harris, M. (2004). The hepatitis C virus NS5A protein binds to members of the Src family of tyrosine kinases and regulates kinase activity. J Gen Virol 85, 721-729.
27. Maeda, N., Watanabe, M., Okamoto, S., Kanai, T., Yamada, T., Hata, J., Hozumi, N., Katsume, A., Nuriya, H. & other authors (2004). Hepatitis C virus infection in human liver tissue engrafted in mice with an infectious molecular clone. Liver Int 24, 259-267.
28. Majumder, M., Ghosh, A. K., Steele, R., Ray, R. & Ray, R. B. (2001). Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner. J Virol 75, 1401-1407.
29. Mellor, J., Holmes, E. C., Jarvis, L. M., Yap, P. L. & Simmonds, P. (1995). Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. J Gen Virol 76, 2493-2507.
30. Miah, S. M., Sada, K., Tuazon, P. T., Ling, J., Maeno, K., Kyo, S., Qu, X., Tohyama, Y., Traugh, J. A. & Yamamura, H. (2004). Activation of Syk protein tyrosine kinase in response to osmotic stress requires the interaction with p21-activated protein kinase Pak2/ γ-PAK. Mol Cell Biol 24, 71-83.
31. Miyanari, Y., Atsuzawa, K., Usuda, N., Watashi, K., Hishiki, T., Zayas, M., Bartenschlager, R., Wakita, T., Hijikata, M. & Shimotohno, K. (2007). The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol 9, 1089-1097.
32. Muramatsu, S., Ishido, S., Fujita, T., Itoh, M. & Hotta, H. (1997). Nuclear localization of the NS3 protein of hepatitis C virus and factors affecting the localization. J Virol 71, 4954-4961.
33. Okamoto, K., Moriishi, K., Miyamura, T. & Matsuura, Y. (2004). Intramembrane proteolysis and endoplasmic reticulum, retention of hepatitis C virus core protein. J Virol 78, 6370-6380.
34. Poole, A., Gibbins, J. M., Turner, M., van Vugt, M. J., van de Winkel, J. G., Saito, T. Tybulewicz, V. L. & Watson, S. P. (1997). The Fc receptor γ-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen. EMBO J 16, 2333-2341.
35. Qadri, I., Iwahashi, M. & Simon, F. (2002). Hepatitis C virus NS5A protein binds TBP and p53, inhibiting their DNA binding and p53 interactions with TBP and ERCC3. Biochim Biophys Acta 1592, 193-204.
36. Reed, K. E. & Rice, C. M. (2000). Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr Top Microbiol Immunol 242, 55-84.
37. Robertson, B., Myers, G, Howard, C., Brettin, T., Eukh, J., Gaschen, B., Gojobori, T., Maertens, G., Mizokami, M. & other authors (1998). Classification, nomenclature, and database development for hepatitis C virus (HCV) and related virus: proposals for standardization. Arch Virol 143, 2493-2503.
38. Sada, K, Zhang, J. & Siraganian, R. P. (2000). Point mutation of a tyrosine in the linker region of Syk results in a gain of function. J Immunol 164, 338-344.
39. Sada, K., Takano, T., Yanagi, S. & Yamamura, H. (2001). Structure and function of Syk protein-tyrosine kinase. J Biochem 130, 177-186.
40. Schneider, F. & Kieser, A. (2004). A novel assay to quantify cell death after transient expression of apoptotic genes in B- and T-lymphocytes. J Immunol Methods 292, 165-174.
41. Shi, S. T., Polyak, S. J., Tu, H., Taylor, D. R., Gretch, D. R. & Lai, M. M. (2002). Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins. Virology 292, 198-210.
42. syk with the γ and β subunits of the high-affiniLy receptor for immunoglobulin E, FcεR1. Mol Cell Biol 15, 272-281.
43. Simon, M., Vanes, L., Geahlen, R. L. & Tybulewicz, V. L. (2005). Distinct roles for the linker region tyrosines of Syk in FcεRI signaling in primary mast cells. J Biol Chem 280, 4510-4517.
44. Song, J., Fujii, M., Wang, F, Itoh, M. & Hotta, H. (1999). The NS5A protein of hepatitis C virus partially inhibits the antiviral activity of interferon. J Gen Virol 80, 879-886.
45. Street A., Macdonald, A., Crowder, K. & Harris, M. (2004). The hepatitis C virus NS5A protein activates a phosphoinositide 3-kinase-dependent survival signaling cascade. J. Biol Chem 279, 12232-12241.
46. Taguchi, T., Nagano-Fujii, M, Akutsu, M., Kadoya, H., Ohgimoto, S., Ishido, S. & Hotta, H. (2004). Hepatitis C virus NS5A protein interacts with 2′,5′-oligoadenylate synthetase and inhibits antiviral activity of IFN in an IFN sensitivity-determining region-independent manner. J Gen Virol 85, 959-969.
47. Takigawa, Y., Nagano-Fujii, M., Deng, L., Hidajat R., Tanaka, M., Mizuta, H. & Hotta, H. (2004). Suppression of hepatitis C virus replicon by RNA interference directed against the NS3 and NS5B regions of the viral genome. Microbiol Immunol 48, 591-598.
48. Tan, S. L., Nakao, H., He, Y., Vijaysri, S., Neddermann, P., Jacobs, B. L., Mayer, B. J. & Katze, M. G. (1999). NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling. Proc Natl Acad Sci U S A 96, 5533-5538.
49. Taniguchi, T., Kobayashi, T., Kondo, J., Takahashi, K., Nakamura, H., Suzuki, J., Nagai, K., Yamada, T., Nakamura, S. & Yamamura, H. (1991). Molecular cloning of a porcine gene syk that encodes a 72-kDa protein-tyrosine kinase showing high susceptibility to proteolysis. J Biol Chem 266, 15790-15796.
50. Tellinghuisen, T. L., Marcotrigiano, J. & Rice, C. M. (2005). Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase. Nature 435, 374-379.
51. Tsuchida, S., Yanagi, S., Inatome, R., Ding, J., Hermann, P., Tsujimura, T., Matsui, T. & Yamamura, H. (2000). Purification of a 72-kDa protein-tyrosine kinase from rat liver and its identification as Syk: involvement of Syk in signaling events of hepatocytes. J Biochem 127, 321-327.
52. Turner, M., Mee, P. J., Costello, P. S., Williams, O., Price, A. A., Duddy, L. P., Furlong, M. T., Geahlen, R. L. & Tybulewicz, V. L. (1995). Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature 378, 298-302.
53. Turner, M., Schweighoffer, E, Colucci, F., Di Santo, J. P. & Tybulewicz, V. L. (2000). Tyrosine kinase SYK: essential functions for immunoreceptor signalling. Immunol Today 21, 148-154.
54. Ulanova, M., Puttagunta, L., Marcet-Palacios, M., Duszyk M., Steinhoff, U., Duta, F., Kim, M. K., Indik, Z. K., Schreiber, A. D. & Befus, A. D. (2005). Syk tyrosine kinase participates in β1-integrin signaling and inflammatory responses in airway epithelial cells. Am Physiol Lung Cell Mol Physiol 288, L497-L507.
55. Wang, S., Ding, Y. B., Chen, G. Y., Xia, J. G. & Wu, Z. Y. (2004). Hypermethylation of Syk gene in promoter region associated with oncogenesis and metastasis of gastric carcinoma. World J Gastroenterol 10, 1815-1818.
56. Weiss, A. & Littman, D. R. (1994). Signal transduction by lymphocyte antigen receptors. Cell 76, 263-274.
57. Wienands, J., Larbolette, O. & Reth, M. (1996). Evidence for a preformed transducer complex organized by the B cell antigen receptor. Proc Natl Acad Sci U S A 93, 7865-7870.
58. Yamada, T., Fujieda, S., Yanagi, S., Yamamura, H., Inatome, R., Sunaga, H. & Saito, H. (2001). Protein-tyrosine kinase Syk expressed in human nasal fibroblasts and its effect on RANTES production. J Immunol 166, 538-543.
59. SYK expressed in hematopoietic cells. Cell Signal 7, 185-193.
60. Yanagi, S., Inatome, R., Ding, J., Kitaguchi, H., Tybulewicz, V. L. & Yamamura, H. (2001). Syk expression in endothelial cells and their morphologic defects in embryonic Syk-deficient mice. Blood 98, 2869-2871.
61. Yasui, K., Wakita, T., Tsukiyama-Kohara, K., Funahashi, S. I., Ichikawa, M., Kajita, T., Moradpour, D., Wands, J. R. & Kohara, M. (1998). The native form and maturation process of hepatitis C virus core protein. J Virol 72, 6048-6055.
62. Yuan, Y., Mendez, R., Sahin, A. & Dai, J. L. (2001). Hypermethylation leads to silencing of the SYK gene in human breast cancer. Cancer Res 61, 5558-5561.
63. Yuan. Y., Wang, J., Li, M., Yan, Z., Zhang, C. & Dai, J. L. (2006). Frequent epigenetic inactivation of spleen tyrosine kinase gene in human hepatocellular carcinoma. Clin Cancer Res. 12, 6687-6695.
64. Zech, B., Kurtenbach, A., Krieger, N., Strand, D., Blencke, S., Morbitzer, M., Salassidis, K., Cotten, M., Wissing, J. & other authors (2003). Identification and characterization of amphiphysin, II as a novel cellular interaction partner of the hepatitis C virus NS5A protein. J Gen Virol 84, 555-560.
65. Zhang, J., Berenstein, E. & Siraganian, R. P. (2002). Phosphorylation of Tyr342 in the linker region of Syk is critical for Fc-εRI signaling in mast cells. Mol Cell Biol 22, 8144-8154.